Significant Ownership of GENERAL ATLANTIC, L.P.
-
Signature - Title
-
/s/ Michael Gosk - Michael Gosk, Managing Director
-
Location
-
New York, NY
-
Summary
-
This page shows a list of all the recent SCHEDULE 13D/G filings made by GENERAL ATLANTIC, L.P..
Notify me when GENERAL ATLANTIC, L.P. files a new Schedule 13D/G report.
⭐ Subscribe ⭐
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of GENERAL ATLANTIC, L.P.
| Sym |
Company |
Class |
Ownership |
Holdings Value |
Net Change |
Nb Shares |
Change % |
Reporting Name |
Report Period |
| DLO |
dLocal Ltd |
Class A common shares, nominal value $0.002 per share |
28% |
$485,229,628 |
|
46,656,695 |
|
GENERAL ATLANTIC, L.P. |
05 Sep 2025 |
| ALKT |
ALKAMI TECHNOLOGY, INC. |
Common stock, par value $0.001 per share |
14% |
$259,348,831 |
+$49,606,041 |
14,879,451 |
+24% |
General Atlantic, L.P. |
16 Oct 2025 |
| AKRO |
Akero Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
8.4% |
$278,656,049 |
|
6,796,489 |
|
General Atlantic, L.P. |
31 Mar 2025 |
| ALHC |
Alignment Healthcare, Inc. |
Class A common stock, par value $0.001 per share |
6.6% |
$280,209,358 |
-$236,622,832 |
13,167,733 |
-46% |
GENERAL ATLANTIC, L.P. |
31 Dec 2025 |
| CHYM |
Chime Financial, Inc. |
Class A Common Stock, par value $0.0001 per share |
5.6% |
$387,440,689 |
|
19,208,760 |
|
General Atlantic, L.P. |
13 Jun 2025 |
| XP |
XP Inc. |
Class A common shares, par value US$0.00001 per share |
5.4% |
$434,238,534 |
|
22,758,833 |
|
GENERAL ATLANTIC, L.P. |
02 Dec 2025 |
| RPRX |
Royalty Pharma plc |
Class A ordinary shares, par value US$0.0001 per share |
3.2% |
$510,500,301 |
|
14,243,870 |
|
General Atlantic, L.P. |
30 Jun 2025 |
| ADAG |
Adagene Inc. |
Ordinary shares, par value US$0.0001 per share |
0% |
$0 |
|
0 |
|
General Atlantic Singapore Fund Pte. Ltd. |
31 Dec 2025 |
| THRD |
Third Harmonic Bio, Inc. |
Common stock, par value $0.0001 |
0% |
$0 |
-$18,663,136 |
0 |
-100% |
General Atlantic, L.P. |
11 Feb 2025 |
| BLND |
Blend Labs, Inc. |
Class A common stock, par value $0.00001 per share |
0% |
$0 |
|
0 |
|
General Atlantic, L.P. |
31 Dec 2024 |
Schedules 13D/G Reported by GENERAL ATLANTIC, L.P.:
| Sym |
Target |
Class |
Ownership |
Change |
Current Shares |
Change |
Value |
Reporting name |
Form |
Report Period |
Filing Date |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.